LORTUSS EX is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Sallus Laboratories, Llc. The primary component is Codeine Phosphate; Guaifenesin; Pseudoephedrine Hydrochloride.
| Product ID | 69036-130_ec543c14-8427-4659-bcc0-3cdcd149ba81 | 
| NDC | 69036-130 | 
| Product Type | Human Otc Drug | 
| Proprietary Name | LORTUSS EX | 
| Generic Name | Codeine Phosphate, Guaifenesin, Pseudoephedrine Hydrochloride | 
| Dosage Form | Liquid | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2014-06-01 | 
| Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL | 
| Application Number | part341 | 
| Labeler Name | Sallus Laboratories, LLC | 
| Substance Name | CODEINE PHOSPHATE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE | 
| Active Ingredient Strength | 10 mg/5mL; mg/5mL; mg/5mL | 
| DEA Schedule | CV | 
| NDC Exclude Flag | E | 
| Listing Certified Through | 2017-12-31 | 
| Marketing Start Date | 2014-06-01 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | OTC MONOGRAPH FINAL | 
| Application Number | part341 | 
| Product Type | HUMAN OTC DRUG | 
| Billing Unit | ML | 
| Marketing Start Date | 2014-06-01 | 
| Marketing End Date | 2019-12-31 | 
| Inactivation Date | 2019-11-27 | 
| Reactivation Date | 2020-05-13 | 
| Ingredient | Strength | 
|---|---|
| CODEINE PHOSPHATE | 10 mg/5mL | 
| SPL SET ID: | 69ee642b-423c-4a68-8c16-cae09d3ef59d | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 69036-130 | LORTUSS | Codeine Phosphate, Guaifenesin, Pseudoephedrine Hydrochloride | 
| 60575-414 | Tricode | Codeine Phosphate, Guaifenesin, Pseudoephedrine Hydrochloride | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  LORTUSS  88817798  not registered Live/Pending | Key Therapeutics, llc 2020-03-02 | 
|  LORTUSS  78149278  2818425 Dead/Cancelled | KOWA PHARMACEUTICALS AMERICA, INC. 2002-07-31 | 
|  LORTUSS  74276053  not registered Dead/Abandoned | WHITBY PHARMACEUTICALS, INC. 1992-05-18 |